To determine whether EpCAM-mediated intestine-specific residence of A33+ Li-EVs was responsible for the maintenance of intestinal tract immune balance, after introducing DSS-induced IBD in mice, we found that EpCAM siRNA-treated mice had more severe IBD than did NC siRNA-treated mice (Fig. 10a). This evidence concerns the gene EPCAM and inflammatory bowel disease.